AVROBIO, Inc. announced the appointment of Philip J. Vickers to its Board of Directors. Dr. Vickers brings a wealth of global pharmaceutical and biotechnology expertise to AVROBIO, with more than 25 year experience in the development and approval of innovative biologics and small molecules to treat diseases in a wide range of therapeutic areas. The company also announced that Scott Requadt is transitioning off AVROBIO’s board to become CEO of a Blackstone portfolio company. Dr. Vickers currently serves as President and CEO of Northern Biologics, Inc.